These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 25910414)
21. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy. Wang Y; Wang S; Shi P Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388 [TBL] [Abstract][Full Text] [Related]
22. Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof. Levacheva I; Samsonova O; Tazina E; Beck-Broichsitter M; Levachev S; Strehlow B; Baryshnikova M; Oborotova N; Baryshnikov A; Bakowsky U Colloids Surf B Biointerfaces; 2014 Sep; 121():248-56. PubMed ID: 25001189 [TBL] [Abstract][Full Text] [Related]
23. Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition. Kopecka J; Salzano G; Campia I; Lusa S; Ghigo D; De Rosa G; Riganti C Nanomedicine; 2014 Jan; 10(1):77-87. PubMed ID: 23850894 [TBL] [Abstract][Full Text] [Related]
24. Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems. Rezaee M; Oskuee RK; Nassirli H; Malaekeh-Nikouei B J Control Release; 2016 Aug; 236():1-14. PubMed ID: 27317365 [TBL] [Abstract][Full Text] [Related]
25. Intradermal and follicular delivery of adapalene liposomes. Kumar V; Banga AK Drug Dev Ind Pharm; 2016; 42(6):871-9. PubMed ID: 27031916 [TBL] [Abstract][Full Text] [Related]
26. Disaccharide-modified liposomes and their in vitro intracellular uptake. Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539 [TBL] [Abstract][Full Text] [Related]
27. Liposomal doxorubicin doubly functionalized with CCK8 and R8 peptide sequences for selective intracellular drug delivery. Ringhieri P; Diaferia C; Galdiero S; Palumbo R; Morelli G; Accardo A J Pept Sci; 2015 May; 21(5):415-25. PubMed ID: 25754969 [TBL] [Abstract][Full Text] [Related]
28. Large-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trial. Wicki A; Ritschard R; Loesch U; Deuster S; Rochlitz C; Mamot C Int J Pharm; 2015 Apr; 484(1-2):8-15. PubMed ID: 25701632 [TBL] [Abstract][Full Text] [Related]
29. Small interfering RNA for cancer treatment: overcoming hurdles in delivery. Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780 [TBL] [Abstract][Full Text] [Related]
30. Effect of surface charge on the size-dependent cellular internalization of liposomes. Sakai-Kato K; Yoshida K; Izutsu KI Chem Phys Lipids; 2019 Nov; 224():104726. PubMed ID: 30660745 [TBL] [Abstract][Full Text] [Related]
31. Microwave-Triggered Smart Drug Release from Liposomes Co-encapsulating Doxorubicin and Salt for Local Combined Hyperthermia and Chemotherapy of Cancer. Jin Y; Liang X; An Y; Dai Z Bioconjug Chem; 2016 Dec; 27(12):2931-2942. PubMed ID: 27998076 [TBL] [Abstract][Full Text] [Related]
32. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity. Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094 [TBL] [Abstract][Full Text] [Related]
33. Asymmetric liposome particles with highly efficient encapsulation of siRNA and without nonspecific cell penetration suitable for target-specific delivery. Mokhtarieh AA; Cheong S; Kim S; Chung BH; Lee MK Biochim Biophys Acta; 2012 Jul; 1818(7):1633-41. PubMed ID: 22465072 [TBL] [Abstract][Full Text] [Related]
34. Two cholesterol derivative-based PEGylated liposomes as drug delivery system, study on pharmacokinetics and drug delivery to retina. Geng S; Yang B; Wang G; Qin G; Wada S; Wang JY Nanotechnology; 2014 Jul; 25(27):275103. PubMed ID: 24960297 [TBL] [Abstract][Full Text] [Related]
35. Formulation optimization and in vivo proof-of-concept study of thermosensitive liposomes balanced by phospholipid, elastin-like polypeptide, and cholesterol. Park SM; Cha JM; Nam J; Kim MS; Park SJ; Park ES; Lee H; Kim HR PLoS One; 2014; 9(7):e103116. PubMed ID: 25068721 [TBL] [Abstract][Full Text] [Related]
36. Non-viral dried powders for respiratory gene delivery prepared by cationic and chitosan loaded liposomes. Colonna C; Conti B; Genta I; Alpar OH Int J Pharm; 2008 Nov; 364(1):108-18. PubMed ID: 18775770 [TBL] [Abstract][Full Text] [Related]
37. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands. Lin W; Xie X; Yang Y; Liu H; Fu X; Chen Y; Liu H; Yang Y J Pharm Pharmacol; 2015 Sep; 67(9):1215-31. PubMed ID: 25880614 [TBL] [Abstract][Full Text] [Related]
38. Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes. Lajunen T; Hisazumi K; Kanazawa T; Okada H; Seta Y; Yliperttula M; Urtti A; Takashima Y Eur J Pharm Sci; 2014 Oct; 62():23-32. PubMed ID: 24810393 [TBL] [Abstract][Full Text] [Related]
39. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration. Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149 [TBL] [Abstract][Full Text] [Related]
40. Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer. Liang X; Gao J; Jiang L; Luo J; Jing L; Li X; Jin Y; Dai Z ACS Nano; 2015 Feb; 9(2):1280-93. PubMed ID: 25599568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]